Cronos (CRON) Treasury Shares (2016 - 2026)
Cronos' (CRON) quarterly Treasury Shares came in at $5.3 million in Q1 2026, up 838.24% year-on-year from $560261.0 in Q1 2025, and down 7.18% quarter-over-quarter from $5.7 million in Q2 2025.
Cronos (CRON) Treasury Shares (2016 - 2026) Analysis & Trends
Cronos' Treasury Shares history runs 10 years deep, the most recent figure standing at $5.3 million for Q1 2026.
- On a quarterly basis, Treasury Shares rose 838.24% year-over-year to $5.3 million in Q1 2026; TTM through Mar 2026 was $5.3 million, a 838.24% increase from a year earlier, with the FY2024 full-year figure at $8.4 million, up 13.56% from the prior year.
- Treasury Shares retreated to $5.3 million in Q1 2026 per CRON's latest filing, from $5.7 million in the prior quarter.
- Across five years, Treasury Shares topped out at $8.4 million in Q3 2024 and bottomed at $560261.0 in Q1 2025.
- The 5-year median for Treasury Shares is $5.5 million (2022), against an average of $5.7 million.
- Across the five-year window, Treasury Shares surged 5801.55% in 2022 and climbed 13.56% in 2024, its largest moves.
- Year by year, Treasury Shares stood at $5.7 million in 2022, then advanced by 28.92% to $7.4 million in 2023, then climbed by 13.56% to $8.4 million in 2024, then sank by 32.44% to $5.7 million in 2025, then retreated by 7.18% to $5.3 million in 2026.
- Per Business Quant, the three latest CRON Treasury Shares figures stand at $5.3 million (Q1 2026), $5.7 million (Q2 2025), and $560261.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | 5.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 560,261.00 |
| Mar 31, 2025 | 560,261.00 |
| Dec 31, 2024 | 8.38 Mn |
| Dec 31, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.39 Mn |
| Sep 30, 2024 | 8.39 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | 4.92 Mn |
| Jun 30, 2022 | 4.92 Mn |
| Mar 31, 2022 | 5.04 Mn |
| Mar 31, 2022 | 5.04 Mn |